课题基金 / 基金详情

A Novel Gnawing Assay to Quantify Nociception in Models of Chronic Orofacial Pain

A Novel Gnawing Assay to Quantify Nociception in Models of Chronic Orofacial Pain
一种量化慢性口面部疼痛模型伤害感受的新型啃咬试验
批准号:
7488578
负责人:
Brian L Schmidt
金额:
$22.92万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2011-02-28

项目摘要

项目成果

Brian L Schmidt的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):慢性口面疼痛影响10%的美国人,目前没有有效的治疗方法。最常见和最严重的口面疼痛形式包括头颈癌疼痛、颞下颌关节疼痛和咀嚼肌疼痛。口面部疼痛患者的主要功能问题是咀嚼疼痛。然而,没有动物行为测定来量化伤害感受对口腔功能的影响,并且与患者的症状相对应。我们假设慢性口面疼痛产生可量化的咀嚼变化。此外,我们假设,减少啃功能可以作为一种措施的伤害感受。为了验证这些假设,我们设计了一种新的装置,该装置可以客观地测量啮齿动物的啃咬功能。在这个项目中,我们将使用我们的新设备来量化头颈癌疼痛,颞下颌关节疼痛和咀嚼肌疼痛动物模型中咀嚼功能的显著损害。为了证实这三种模型中改变的啃咬功能是继发于疼痛的,我们将证明临床上用于治疗这些形式的慢性疼痛的药物的逆转。我们预计,我们的工作将从根本上提高三叉神经系统的伤害性机制的理解,提供一个定量的功能伤害性测定,不依赖于主观的行为解释,不需要观察时间的调查。
英文摘要
DESCRIPTION (provided by applicant): Chronic orofacial pain affects 10% of Americans and there currently is no effective treatment. The most common and most severe forms of orofacial pain include head and neck cancer pain, TMJ pain and masticatory muscle pain. The primary functional problem for orofacial pain patients is pain with chewing. However, there is no animal behavioral assay that quantifies the impact of nociception on oral function and that parallels the symptoms of patients. We hypothesize that chronic orofacial pain produces quantifiable masticatory changes. Moreover, we hypothesize that reduced gnawing function can be used as a measure of nociception. To test these hypotheses we have designed, custom built and pilot tested a novel device that objectively measures gnawing function in rodents. In this project we will use our novel device to quantify significant impairment of gnawing function in animal models of head and neck cancer pain, TMJ pain and masticatory muscle pain. To confirm that the altered gnawing function in the three models is secondary to pain we will demonstrate reversal with agents used clinically to treat these forms of chronic pain. We anticipate that our work will contribute fundamentally to improved understanding of nociceptive mechanisms of the trigeminal system by providing a quantitative functional nociceptive assay that does not depend on subjective behavioral interpretation and does not require observational time by an investigator.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.
口服鳞状细胞癌中甲基化的EDNRB基因的重新表达会减弱癌症引起的疼痛。
DOI: 10.1016/j.pain.2011.06.025
发表时间: 2011-10
期刊: Pain
影响因子: 7.4
作者: [Viet CT, Ye Y, Dang D, Lam DK, Achdjian S, Zhang J, Schmidt BL]
通讯作者: Schmidt BL
DOI: 10.1016/j.pain.2010.02.009
发表时间: 2010-05
期刊: Pain
影响因子: 7.4
作者: [Quang PN, Schmidt BL]
通讯作者: Schmidt BL
DOI: 10.1016/j.jpain.2009.10.011
发表时间: 2010-07
期刊: The journal of pain
影响因子: --
作者: [Quang PN, Schmidt BL]
通讯作者: Schmidt BL
DOI: 10.1016/j.pain.2010.02.010
发表时间: 2010-05
期刊: Pain
影响因子: 7.4
作者: [Lam DK, Schmidt BL]
通讯作者: Schmidt BL
Intratumor co-delivery of DNA and RNA to relieve cancer pain
  • 批准号:
    10543510
  • 项目类别:
  • 资助金额:
    $58.38万
  • 财政年份:
    2021
  • 负责人:
    Brian L Schmidt
  • 依托单位:
Intratumor co-delivery of DNA and RNA to relieve cancer pain
  • 批准号:
    10327329
  • 项目类别:
  • 资助金额:
    $57.37万
  • 财政年份:
    2021
  • 负责人:
    Brian L Schmidt
  • 依托单位:
Non-viral gene therapy for cancer pain
  • 批准号:
    9195859
  • 项目类别:
  • 资助金额:
    $40.71万
  • 财政年份:
    2016
  • 负责人:
    Brian L Schmidt
  • 依托单位:
Non-viral gene therapy for cancer pain
  • 批准号:
    9284436
  • 项目类别:
  • 资助金额:
    $40.16万
  • 财政年份:
    2016
  • 负责人:
    Brian L Schmidt
  • 依托单位:
海外基金